Sterile & Parenteral
Aseptic processing, terminal sterilization, media fill, contamination control and sterile utilities.

PHARMACEUTICAL GMP • QUALITY • VALIDATION
AVISAN helps pharmaceutical manufacturers and distribution companies turn requirements into controlled, evidence-based, inspection-defensible execution.
AVISAN CONTROL MODEL
Services overview
From quality-system design and technical documentation to qualification, shopfloor execution and inspection readiness.
System-level reviews that connect written requirements with execution, ownership and available evidence.
VIEW SERVICE↗02Risk-based readiness plans, evidence-room preparation, walkthroughs and challenge-response support.
VIEW SERVICE↗03QMS design and improvement across deviation, CAPA, change control, PQR, training and management review.
VIEW SERVICE↗04ICH Q9-aligned risk governance, specialized audits, supplier oversight and defensible decisions.
VIEW SERVICE↗05VMP, DQ, IQ, OQ and PQ strategies for equipment, facilities, utilities, processes and cleaning.
VIEW SERVICE↗06Quality oversight for HVAC, cleanrooms, PW/WFI, compressed gases, mapping and lifecycle control.
VIEW SERVICE↗07Support for aseptic, terminally sterilized, OSD, softgel, potent and biotech operations.
VIEW SERVICE↗08GDP/GSP systems, temperature mapping, transport qualification, warehousing and vendor control.
VIEW SERVICE↗09SOPs, SMF, URS, protocols, reports, layouts, CTD support and role-based GMP training.
VIEW SERVICE↗Industries & operations
AVISAN support is structured around the product, process and facility risks that define each operating environment.
Aseptic processing, terminal sterilization, media fill, contamination control and sterile utilities.
Tablets, capsules, coating, granulation, cleaning and general or potent manufacturing.
Containment, cross-contamination control, cleaning validation and engineering controls.
Upstream and downstream operations, classified flows, utilities and process support systems.
GDP, storage, cold chain, temperature mapping, transport and vendor governance.
How we work
We connect documents, decisions and shopfloor evidence so the system can defend itself under inspection.
Documents describe the system. Evidence proves it is in control.
Selected experience
Representative scopes from real pharmaceutical work. Client and site identities remain confidential.
CLIENT CONFIDENTIAL
Jul 2024–PresentSterile injectable companyCustomized GMP training for production, QC and QA, together with integrated QMS implementation across SOPs, deviation, CAPA and internal audit, plus ongoing compliance and inspection-readiness support.
CLIENT CONFIDENTIAL
Dec 2022–Apr 2024Sterile manufacturing siteComprehensive support covering PW/WFI qualification, HVAC, process and cleaning validation, GMP documentation, personnel training and operational readiness through GMP approval.
CLIENT CONFIDENTIAL
Mar–May 2023Sterile manufacturing facilityDesign review, FAT/SAT supervision, PQ protocol preparation and execution, sampling and monitoring strategy, and risk-based validation documentation.
CLIENT CONFIDENTIAL
Current engagementParenteral projectQuality-system architecture, core GMP documentation, layout and flow review, qualification alignment, practical execution support and personnel readiness.
CLIENT CONFIDENTIAL
Selected projectPharmaceutical storageMapping strategy, protocol and sensor-location review, execution support, data assessment, deviation handling and final-report structure.
CLIENT CONFIDENTIAL
Selected projectPharmaceutical facilityGMP documentation development, layout and personnel/material-flow review, role-based training and implementation support.
Insights
Short, experience-led observations on the gaps between paper compliance and controlled execution.
Design is defensible only when actual personnel and material movement are verified against it.
READ NOTE ↗The risk window must start from the earliest plausible failure — not the next scheduled test.
READ NOTE ↗A passed protocol is not enough when operating ranges, alarms and routine decisions remain unverified.
READ NOTE ↗About AVISAN
AVISAN brings together pharmaceutical quality, validation, engineering and regulatory thinking to help organizations build systems that work in routine operation — not only on paper. Engagements can be delivered remotely, on-site or through a hybrid model across the Middle East.
Recommendations are designed for implementation.
Effort follows product, patient and compliance risk.
Control is demonstrated through traceable evidence.
Decisions and execution must withstand challenge.